COVID-19 vaccines: how to ensure Africa has access

nature "History must not repeat itself — global and continental cooperation are essential. - Last month, a grand experiment was launched. Its aim? To speed up the development of COVID‑19 vaccines and make sure they are distributed equitably among higher- and lower-income countries. This welcome endeavour is called the COVID-19 Vaccine Global Access (COVAX) initiative. It is co-led by the World Health Organization (WHO), the Coalition for Epidemic Preparedness Innovations (CEPI) and Gavi, the Vaccine Alliance. (...) Still, Africa has reasons to worry. Already, several hghi-income countries have signed their own contracts with individual companies to buy selected vaccines. The United States, for example, has made deals worth upwards of US$6 billion with several firms. An analysis by the international charity Oxfam finds that, even if all five of the most-advanced vaccine candidates succeed, there will not be enough vaccine for most of the world’s people until 2022." (Photo: PATH global health/flickr, CC BY 2.0)

• www.nature.com